Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 5.5.2025Wörwag Pharma GmbH & Co. KG (WGP-1)67050Magnerot (tbl 50x500 mg (blis.PVC/PVDC/Al))5.5.2025O
 5.5.2025Egis Pharmaceuticals PLC (EGI)77012Escitil 15 mg (tbl flm 56x15 mg (blis. OPA/Al/PVC/Al))5.5.2025O
 5.5.2025B.Braun Melsungen AG (BME)32441Aqua pro injectione Braun (lif par 100x10 ml (amp.PP))5.5.2025O
 5.5.2025Zentiva, k.s. (ZNT-1)0375BTramadol/Paracetamol Zentiva 75 mg/650 mg (tbl flm 30x75 mg/650 mg (blis.PVC/PVDC/Al))5.5.2025O
 5.5.2025Zentiva, k.s. (ZNT-1)5323BZenaro 5 mg (tbl flm 20x5 mg (blis.PVC/PE/PVDC/Al))5.5.2025O
 5.5.2025Grifols Deutschland GmbH (GIO)4990CGamunex (sol inf 1x400 ml (liek.inj.skl.))5.5.2025R
 5.5.2025Viatris Limited (VIM)35235Alfuzosin Viatris 10 mg (tbl plg 60x10 mg (blis.PVC/PVDC/Al))31.7.2025Z
 5.5.2025Viatris Limited (VIM)5629EDabigatran Etexilate Viatris 110 mg tvrdé kapsuly (cps dur 60x110 mg (blis.Al/OPA/Al/PVC))30.6.2025Z
 5.5.2025Viatris Limited (VIM)5639EDabigatran Etexilate Viatris 150 mg tvrdé kapsuly (cps dur 60x150 mg (blis.Al/OPA/Al/PVC))30.6.2025Z
 5.5.2025Vipharm S.A. (VIH-PL-1)2209DEverolimus Vipharm 5 mg tablety (tbl 30x5 mg (blis.Al/Al))26.5.2025R
 5.5.2025Vipharm S.A. (VIH-PL-1)2647DAsduter 15 mg tablety (tbl 56x15 mg (fľ.HDPE s PP uzáv.))12.5.2025R
 5.5.2025Merck Sharp & Dohme B.V. (MSD-NL)9027EWELIREG 40 mg filmom obalené tablety (tbl flm 90 (3x30)x40 mg (blis.Al/Al))2.5.2025U
 2.5.2025Dr. Falk Pharma GmbH (FAK)64786Budenofalk 3 mg gastrorezistentné kapsuly (cps ent 50x3 mg (blis.Al/PVC/PVDC))2.5.2025R
 2.5.2025Teva B.V. (TEV-NL-4)8439CErlotinib Teva B.V. 100 mg (tbl flm 30x100 mg (blis. Al/PVC))30.7.2025Z
 30.4.2025Teva B.V. (TEV-NL-4)34950MEGESIN 160 mg (tbl 100x160 mg)1.6.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To